Publications

Title	Date	PC3I Authors	Journal
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy	November 9, 2022	PC3I Authors Haley Newman; Allison Barz Leahy	Blood
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia	October 11, 2023	PC3I Authors Allison Barz Leahy	Transplantation and Cellular Therapy
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research	April 4, 2024	PC3I Authors Haley Newman; Alix Seif; Allison Barz Leahy	Cancer Medicine
Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy	May 4, 2021	PC3I Authors Allison Barz Leahy; Lisa A. Schwartz	Cancer
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials	September 24, 2021	PC3I Authors Allison Barz Leahy; Haley Newman	The Lancet Haematology
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy	December 6, 2021	PC3I Authors Allison Barz Leahy; Haley Newman	Blood
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia	December 6, 2021	PC3I Authors Allison Barz Leahy; Alix Seif	Blood Advances
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19	June 15, 2022	PC3I Authors Alix Seif; Allison Barz Leahy; Haley Newman	Clinical Cancer Research
Capturing the young child’s reports of cancer treatment tolerability: Does our practice reflect an assumption that they cannot report?	October 17, 2022	PC3I Authors Allison Barz Leahy	Pediatric Blood and Cancer
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia	October 31, 2022	PC3I Authors Allison Barz Leahy	Leukemia